Summary & Overview
HCPCS P9020: Platelet Rich Plasma, Each Unit
HCPCS Level II code P9020 denotes a unit of platelet rich plasma (PRP), a blood-derived biologic product used in regenerative medicine and wound care. PRP is increasingly utilized across specialties for its potential to support tissue repair, and consistent coding for PRP units matters for clinical documentation, billing accuracy, and payer coverage determinations nationwide. This analysis addresses national implications of standardized reporting for PRP units and what stakeholders should expect when encountering this code.
Key payers covered in this review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise primer on the clinical context of PRP, typical sites of service where PRP is prepared and applied, and the billing mechanics tied to P9020. The publication summarizes common modifiers and operational coding considerations, highlights typical payer coverage conversations, and outlines where readers can find related codes and documentation needs. The focus is on providing clear, nationally relevant benchmarks for coding and administrative processes rather than jurisdiction-specific policy guidance. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code P9020 represents platelet rich plasma, each unit, a biologic product derived from a patient’s own blood that concentrates platelets for use in regenerative and wound care applications. The service type is biologic blood-derived product preparation and administration, and the typical site of service includes outpatient clinics, ambulatory surgery centers, physician offices, and wound care centers where collection, processing, and application occur.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45-year-old recreational athlete with chronic lateral epicondylosis (tennis elbow) refractory to conservative care including physical therapy, NSAIDs, and corticosteroid injection. The clinician (orthopedic surgeon or sports medicine specialist) evaluates the patient, documents failed conservative management, obtains informed consent for an autologous platelet-rich plasma (PRP) injection, and documents contraindications (active infection, platelet dysfunction, anticoagulation review). On the day of service, venipuncture is performed to draw the patient’s blood, which is processed in a centrifuge to concentrate platelets into a unit of PRP. The clinician or trained staff prepare the injection field under aseptic technique; ultrasound guidance is commonly used to target the affected tendon. The PRP unit (billed as P9020) is administered via injection into the tendon or surrounding tissue. Post-procedure documentation includes the volume and lot/unit identifier for the PRP, procedural note, ultrasound images if used, and instructions for activity modification and follow-up. Typical site of service: outpatient physician office, ambulatory surgical center, or hospital outpatient department. Typical service type: biologic autologous blood-derived product for therapeutic injection into soft tissues.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |